<DOC>
	<DOCNO>NCT00518518</DOCNO>
	<brief_summary>The aim study assess safety efficacy sublingual immunotherapy apply preseasonal seasonal ultra-rush scheme child bronchial asthma allergic grass pollen . The investigator assess clinical symptom , reliever drug usage , lung function , choose marker allergic inflammation , bronchial hyperreactivity methacholine , presence type allergy two year sublingual immunotherapy ( SLIT ) child asthma .</brief_summary>
	<brief_title>Safety Efficacy Ultra-Rush Sublingual Immunotherapy Children With Asthma Allergic Grass Pollen</brief_title>
	<detailed_description>Specific immunotherapy causal treatment method atopic diseases include bronchial asthma child . Sublingual immunotherapy seem promising alternative traditional specific subcutaneous injection immunotherapy . The aim study assess safety efficacy sublingual immunotherapy apply preseasonal seasonal ultra-rush scheme child bronchial asthma allergic grass pollen . We assess clinical symptom , reliever drug usage , lung function , choose marker allergic inflammation , bronchial hyperreactivity methacholine , presence type allergy two year SLIT child asthma . After two year study unblinded , child give grass pollen allergen extract year .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>patient allergic grass pollen patient bronchial asthma patient control asthma patient qualify immunotherapy give write informed consent immunotherapy patient allergic perennial seasonal allergen patient chronic disease either put patient risk participate study could influence result study patient 's ability participate study judge investigator</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Sublingual immunotherapy</keyword>
	<keyword>Children</keyword>
</DOC>